UCB makes major management changes; Bristol Myers’ ADC partner tops list of new CEOs
→ UCB is shaking up its leadership team “to better align with its commitment to growth and innovation, and to better address the dynamic external
→ UCB is shaking up its leadership team “to better align with its commitment to growth and innovation, and to better address the dynamic external
Recursion Pharmaceuticals has poached Najat Khan from Johnson & Johnson, where she led AI efforts at one of healthcare’s giants. Khan will serve as chief
Another executive is out at Illumina. The DNA sequencing company said earlier this week that CFO Joydeep Goswami will exit and the position will be taken
→ Just a few weeks after Amgen touted its efforts in rare disease, EVP of R&D in that therapeutic area is departing to lead R&D at
Mythic Therapeutics has gone more than a year and a half without a CEO. That’s changing on April 1, as George Eliades will join the
→ Jamie Macdonald will retire as CEO of Parexel on May 15, and the clinical research organization has already named Peyton Howell — the current
→ Biogen chief medical officer Maha Radhakrishnan is out after four years “as of March 1,” a spokesperson tells Peer Review. Biogen didn’t draw up
After six years as head of clinical development at Apellis Pharmaceuticals, Ramiro Ribeiro is joining EyePoint Pharmaceuticals as CMO. “The retinal community is relatively small,
“I wish I was a bat,” Theresa Heah says. The two-decade industry veteran has glided into a new CEO post at Paratus Sciences, a Polaris
→ A spokesperson for Takeda tells Peer Review that PK Morrow succeeded Chris Arendt as head of oncology on Jan. 29. A few weeks ago